• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋微藻鲁莽陀螺藻菌株KG03硫酸化胞外多糖的抗病毒作用

Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03.

作者信息

Yim Joung Han, Kim Sung Jin, Ahn Se Hun, Lee Chong Kyo, Rhie Ki Tae, Lee Hong Kum

机构信息

Microbiology Laboratory, Korea Ocean Research & Development Institute, Ansan P.O. Box 29, Seoul 425-600, Republic of Korea.

出版信息

Mar Biotechnol (NY). 2004 Jan-Feb;6(1):17-25. doi: 10.1007/s10126-003-0002-z. Epub 2003 Sep 29.

DOI:10.1007/s10126-003-0002-z
PMID:14508657
Abstract

The sulfated exopolysaccharide p-KG03, which is produced by the marine microalga Gyrodinium impudicum strain KG03, exhibited impressive antiviral activity in vitro (EC50 = 26.9 micro g/ml) against the encephalomyocarditis virus (EMCV). Depending on the p-KG03 concentration, the development of cytopathic effects in EMCV-infected HeLa cells was either inhibited completely or slowed. Moreover, p-KG03 did not show any cytotoxic effects on HeLa cells, even at concentrations up to 1000 microg/ml. The polysaccharide was purified by repeated precipitation in ethanol, followed by gel filtration. The p-KG03 polysaccharide had a molecular weight of 1.87 x 10(7), and was characterized as a homopolysaccharide of galactose with uronic acid (2.96% wt/wt) and sulfate groups (10.32% wt/wt). The biological activities of p-KG03 suggest that sulfated metabolites from marine organisms are a rich source of antiviral agents. This is the first reported marine source of antiviral sulfated polysaccharides against EMCV. The p-KG03 polysaccharide may be useful in the development of marine bioactive exopolysaccharide for biotechnological and pharmaceutical products.

摘要

由海洋微藻裸甲藻菌株KG03产生的硫酸化胞外多糖p-KG03,在体外对脑心肌炎病毒(EMCV)表现出显著的抗病毒活性(EC50 = 26.9微克/毫升)。根据p-KG03的浓度,EMCV感染的HeLa细胞中细胞病变效应的发展要么被完全抑制,要么减缓。此外,即使在浓度高达1000微克/毫升时,p-KG03对HeLa细胞也未显示出任何细胞毒性作用。该多糖通过在乙醇中反复沉淀,然后进行凝胶过滤进行纯化。p-KG03多糖的分子量为1.87×10⁷,其特征为含有糖醛酸(2.96%重量/重量)和硫酸基团(10.32%重量/重量)的半乳糖同多糖。p-KG03的生物活性表明,海洋生物的硫酸化代谢产物是抗病毒剂的丰富来源。这是首次报道的针对EMCV的海洋来源抗病毒硫酸化多糖。p-KG03多糖可能有助于开发用于生物技术和医药产品的海洋生物活性胞外多糖。

相似文献

1
Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03.海洋微藻鲁莽陀螺藻菌株KG03硫酸化胞外多糖的抗病毒作用
Mar Biotechnol (NY). 2004 Jan-Feb;6(1):17-25. doi: 10.1007/s10126-003-0002-z. Epub 2003 Sep 29.
2
Characterization of a novel bioflocculant, p-KG03, from a marine dinoflagellate, Gyrodinium impudicum KG03.从海洋甲藻裸甲藻KG03中鉴定一种新型生物絮凝剂p-KG03。
Bioresour Technol. 2007 Jan;98(2):361-7. doi: 10.1016/j.biortech.2005.12.021. Epub 2006 Feb 10.
3
Novel sulfated polysaccharide derived from red-tide microalga Gyrodinium impudicum strain KG03 with immunostimulating activity in vivo.源自赤潮微藻海洋陀螺藻菌株KG03的具有体内免疫刺激活性的新型硫酸化多糖。
Mar Biotechnol (NY). 2005 Jul-Aug;7(4):331-8. doi: 10.1007/s10126-004-0404-6. Epub 2005 Jun 4.
4
In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03.海洋微藻来源硫酸化多糖 p-KG03 体外抗甲型流感病毒感染作用
Antiviral Res. 2012 Feb;93(2):253-259. doi: 10.1016/j.antiviral.2011.12.006. Epub 2011 Dec 14.
5
Optimal conditions for the production of sulfated polysaccharide by marine microalga Gyrodinium impudicum strain KG03.海洋微藻裸甲藻菌株KG03生产硫酸化多糖的最佳条件。
Biomol Eng. 2003 Jul;20(4-6):273-80. doi: 10.1016/s1389-0344(03)00070-4.
6
Axenic culture of Gyrodinium impudicum strain KG03, a marine red-tide microalga that produces exopolysaccharide.海洋赤潮微藻裸甲藻KG03菌株的无菌培养,该菌株可产生胞外多糖。
J Microbiol. 2004 Dec;42(4):305-14.
7
In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses.一种海洋微藻(多边舌甲藻)硫酸化多糖对人类免疫缺陷病毒及其他包膜病毒的体外抗病毒活性
Int J Biol Macromol. 1995 Oct;17(5):293-7. doi: 10.1016/0141-8130(95)98157-t.
8
Retraction notice to "Activation of murine peritoneal macrophages by sulfated exopolysaccharide from marine microalga Gyrodinium impudicum (strain KG03): Involvement of the NF-κB and JNK pathway" [Int. Immunopharmacol. 6(3) (2006) 473-484].撤回通知:“海洋微藻裸甲藻(菌株KG03)的硫酸化胞外多糖对小鼠腹腔巨噬细胞的激活作用:NF-κB和JNK信号通路的参与”[《国际免疫药理学》6(3) (2006) 473 - 484]
Int Immunopharmacol. 2021 Oct;99:107981. doi: 10.1016/j.intimp.2021.107981. Epub 2021 Jul 23.
9
Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.从海藻中提取的硫酸化多糖作为潜在的抗病毒药物。
Gen Pharmacol. 1997 Oct;29(4):497-511. doi: 10.1016/s0306-3623(96)00563-0.
10
In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis.龙须菜硫酸多糖组分的体外抗流感病毒活性。
Virol Sin. 2010 Oct;25(5):341-51. doi: 10.1007/s12250-010-3137-x. Epub 2010 Oct 8.

引用本文的文献

1
Microalgal diversity, nutritional profiles, and applications in poultry nutrition: A comprehensive review.微藻多样性、营养成分及其在家禽营养中的应用:综述
Anim Nutr. 2025 Jun 5;22:426-441. doi: 10.1016/j.aninu.2025.02.010. eCollection 2025 Sep.
2
Microalgae: A Promising Source of Bioactive Polysaccharides for Biotechnological Applications.微藻:生物技术应用中生物活性多糖的一个有前景的来源。
Molecules. 2025 May 5;30(9):2055. doi: 10.3390/molecules30092055.
3
Antimicrobial properties of selected microalgae exopolysaccharide-enriched extracts: influence of antimicrobial assays and targeted microorganisms.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Protective effect of seaweed extracts for chicken embryos infected with influenza B or mumps virus.海藻提取物对感染乙型流感病毒或腮腺炎病毒的鸡胚的保护作用。
Proc Soc Exp Biol Med. 1958 Dec;99(3):590-3. doi: 10.3181/00379727-99-24429.
3
Establishment and use of a cell line expressing HSV-1 thymidine kinase to characterize viral thymidine kinase-dependent drug-resistance.建立并使用表达单纯疱疹病毒1型胸苷激酶的细胞系来鉴定病毒胸苷激酶依赖性耐药性。
所选富含微藻胞外多糖提取物的抗菌特性:抗菌测定和目标微生物的影响
Front Microbiol. 2025 Jan 28;16:1536185. doi: 10.3389/fmicb.2025.1536185. eCollection 2025.
4
Biomedical engineering utilizing living photosynthetic cyanobacteria and microalgae: Current status and future prospects.利用光合蓝细菌和微藻的生物医学工程:现状与未来展望。
Mater Today Bio. 2024 Jul 14;27:101154. doi: 10.1016/j.mtbio.2024.101154. eCollection 2024 Aug.
5
Characterization and optimization of exopolysaccharide extracted from a newly isolated halotolerant cyanobacterium, Acaryochloris Al-Azhar MNE ON864448.1 with antiviral activity.从新分离的具有抗病毒活性的耐盐蓝藻阿扎卡里亚绿藻(Acaryochloris Al-Azhar MNE ON864448.1)中提取的胞外多糖的表征与优化
Microb Cell Fact. 2024 Apr 22;23(1):117. doi: 10.1186/s12934-024-02383-4.
6
Sulfated Polysaccharides from Seaweeds: A Promising Strategy for Combatting Viral Diseases-A Review.海藻硫酸多糖:对抗病毒性疾病的一种有前景的策略——综述
Mar Drugs. 2023 Aug 23;21(9):461. doi: 10.3390/md21090461.
7
Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses.海洋硫酸化糖缀合物对人致病性冠状病毒的抗病毒活性。
Sci Rep. 2023 Mar 23;13(1):4804. doi: 10.1038/s41598-023-31722-5.
8
Microalgal bioactive metabolites as promising implements in nutraceuticals and pharmaceuticals: inspiring therapy for health benefits.微藻生物活性代谢产物作为营养保健品和药品中有前景的工具:激发有益健康的疗法。
Phytochem Rev. 2023 Jan 14:1-31. doi: 10.1007/s11101-022-09848-7.
9
The nanomolar affinity of C-phycocyanin from virtual screening of microalgal bioactive as potential ACE2 inhibitor for COVID-19 therapy.微藻生物活性物质虚拟筛选出的C-藻蓝蛋白作为治疗COVID-19的潜在ACE2抑制剂的纳摩尔亲和力。
J King Saud Univ Sci. 2023 Apr;35(3):102533. doi: 10.1016/j.jksus.2022.102533. Epub 2023 Jan 5.
10
Extracellular Polymeric Substances: Still Promising Antivirals.细胞外多聚物:依旧有潜力的抗病毒物质。
Viruses. 2022 Jun 19;14(6):1337. doi: 10.3390/v14061337.
Antiviral Res. 2002 Jun;54(3):163-74. doi: 10.1016/s0166-3542(01)00221-2.
4
Anti-HIV activity of extracts and compounds from algae and cyanobacteria.藻类和蓝细菌提取物及化合物的抗艾滋病毒活性
Ecotoxicol Environ Saf. 2000 Mar;45(3):208-27. doi: 10.1006/eesa.1999.1862.
5
Phylogenetic analysis of European encephalomyocarditis viruses: comparison of two genomic regions.欧洲脑心肌炎病毒的系统发育分析:两个基因组区域的比较
Arch Virol. 1999;144(5):893-903. doi: 10.1007/s007050050554.
6
In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses.一种海洋微藻(多边舌甲藻)硫酸化多糖对人类免疫缺陷病毒及其他包膜病毒的体外抗病毒活性
Int J Biol Macromol. 1995 Oct;17(5):293-7. doi: 10.1016/0141-8130(95)98157-t.
7
Inhibition of reverse transcriptase activity by extracts of cultured blue-green algae (cyanophyta).培养的蓝藻(蓝藻门)提取物对逆转录酶活性的抑制作用。
Planta Med. 1993 Apr;59(2):148-51. doi: 10.1055/s-2006-959631.
8
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.用于细胞生长和存活的快速比色测定法:应用于增殖和细胞毒性测定。
J Immunol Methods. 1983 Dec 16;65(1-2):55-63. doi: 10.1016/0022-1759(83)90303-4.
9
New method for quantitative determination of uronic acids.糖醛酸定量测定的新方法。
Anal Biochem. 1973 Aug;54(2):484-9. doi: 10.1016/0003-2697(73)90377-1.
10
AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae).来自蓝细菌(蓝藻)的抗艾滋病病毒硫脂。
J Natl Cancer Inst. 1989 Aug 16;81(16):1254-8. doi: 10.1093/jnci/81.16.1254.